Q3 2025 Pediatrix Medical Group Inc Earnings Call Transcript
Key Points
- Pediatrix Medical Group Inc (MD) exceeded expectations with an adjusted EBITDA of $87 million for the third quarter.
- The company achieved strong same-unit growth of 8%, with same-unit pricing up about 7.5%.
- Pediatrix Medical Group Inc (MD) successfully bought back 1.7 million shares, reflecting a strategic use of capital.
- The company generated $138 million in operating cash flow in the third quarter, a significant increase from the prior year.
- Pediatrix Medical Group Inc (MD) maintains a strong market position with a substantial clinical footprint, serving patients in 322 locations across 33 states.
- Consolidated revenue decreased due to portfolio restructuring activity, resulting in a reduction of just under $54 million.
- There is a wider-than-usual range for the full year's adjusted EBITDA outlook due to practice bonus variability.
- The company faces challenges in obtaining contract administrative fee increases due to pressures faced by hospitals.
- General and administrative expenses increased slightly year-over-year, driven by higher incentive compensation expenses.
- The company acknowledges significant healthcare headwinds, which could impact future operations and results.
Ladies and gentlemen, thank you for standing by. Hello. My name is Dustin, and I will be your conference operator today. At this time, I would like to welcome you to third-quarter 2025 Pediatrix Medical Group Incorporated earnings conference call. (Operator Instructions)
I would now like to turn the conference over to our Chief Administrative Officer, Mary Ann Moore. Please go ahead.
Thank you, operator, and good morning. Certain statements and information during this call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on assumptions and assessments made by pediatrics management in light of their experience and assessment of historical trends, current conditions, expected future developments and other factors they believe to be appropriate.
Any forward-looking statements made during this call are made as of today, and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
